In this episode Charlie Piermarini and Stephanie Ochoa interview Dr. Leyfeldt about her role in medical cannabis education. She explains how past education about cannabis involves only recognizing intoxication in the emergency room and how Western medicine is limited to single agent pharmaceuticals. Dr. Leyfeldt reflects on the complexity of the cannabis plant and the …
CBD continues to be in the gray area in the eyes of the FDA and all other 3 lettered agencies. Stephanie and Charlie discuss the FDA’s newest “ruling” about CBD in regards to its legal status. Legitimate CBD and hemp business owners in the industry want regulation so they know what the rules are to …
Come listen as we discuss recently published JAMA article titled, ” State Cannabis legalization and Psychosis- Related Health Care Utilization”. It is a robust retrospective study looking at the effects of legalized cannabis on psychosis diagnosis. Link to article: https://jamanetwork.com/journals/jama…
Stephanie Ochoa, PA-C and Charlie Piermarini, PA-C discuss a recently published research article about Cannabis use in pregnant woman from the Healthy Start program in Colorado. This was a NIH funded paper, which is great and shows the progress the field is making. But, were the conclusions and study design fair? Here is a copy …
We break down the most recent MedScape video and JAMA article Is it fair to assume that CBD has psychoactive effects based off a study of 18 participants? Well Medscape made that conclusion. Stephanie and Charlie break down the study published in JAMA and point out the flaws in the study and the flaws in …
